An observational study in Pneumonia and Orotracheal Intubation, sponsored by University Hospital, Clermont-Ferrand. Not yet recruiting at 6 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-27.
Sponsored by University Hospital, Clermont-Ferrand · Observational
Orotracheal intubation in emergency medicine is a vital procedure for ensuring adequate oxygenation and ventilation in patients with respiratory distress or in shock. However, this procedure exposes patients to complications such as pneumonia. In the matter of fact, the urgency of the procedure means that it is not possible to wait until the patient's stomach is empty. Pneumonia significantly increase patient morbidity and mortality. Therapeutic management must be early and appropriate to improve the patient's prognosis.
The aim of this study is to compare the rate of pneumonia occurring in patients intubated in emergency situations with that in patients intubated in non-emergency situations in all 2024. Health data will only collected from patient's medical records.
2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.
This study's planned enrollment of 600 is above the median of 203 across 688 observational studies indexed under Pneumonia.
Browse Pneumonia studies →University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Study population is patient intubated in emergency situation and patients intubated in non-emergency situation following to the admission of intensive care in 2024.
Exclusion Criteria:
Health data will be collected only with medical's record of intubated patients in emergency situation in 2024.
Health data will be collected only with medical's record of intubated patients in non emergency situation in 2024.
Pneumonia rate in 48 hours after the start of orotracheal intubation.
Rate of pneumonia occuring within 48 hours of the start of orotracheal intubation.
Time frame: Hour 48
Pneumonia rate occuring 48 hours after the start of orotracheal intubation.
Rate of pneumonia occuring more than 48 hours after the start of orotracheal intubation.
Time frame: 3 months
Duration of mechanical ventilation
Duration of mechanical ventilation
Time frame: Up to the end of mechanical ventilation (assessed up to 1 month)
Duration of stay in intensive care
Duration of stay in intensive care
Time frame: Up to intensive care discharge (assessed up to 1 month)
Duration of hospital stay
Duration of hospital stay
Time frame: Up to hospital discharge (assessed up to 3 months)
Mortality rate
Mortality rate
Time frame: Inclusion + 1 year
Type of bacteria responsible for pneumonia
The bacterial species responsible for pneumonia will be identified using biological samples (blood, urine, bronchial secretions) taken from patients in both groups. The identification of bacterial species will be carried out in the laboratory.
Time frame: The day of the diagnosis of pneumonia (assessed up to 1 month)
Type of antibiotic administered for pneumonia
Type of antibiotic administered for pneumonia in each group
Time frame: Up to the last day of antibiotic treatment (assessed up to 3 months)
Antibiotic doses administered for pneumonia
Comparison of antibiotic doses in g or mg administered in each group
Time frame: Up to the last day of antibiotic treatment (assessed up to 3 months)
Duration of antibiotic treament for pneumonia
Duration of antibiotic treament for pneumonia in each group
Time frame: Up to the last day of antibiotic treatment (assessed up to 3 months)
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand